Correlation Between AcelRx Pharmaceuticals and SNDL
Can any of the company-specific risk be diversified away by investing in both AcelRx Pharmaceuticals and SNDL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AcelRx Pharmaceuticals and SNDL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AcelRx Pharmaceuticals and SNDL Inc, you can compare the effects of market volatilities on AcelRx Pharmaceuticals and SNDL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AcelRx Pharmaceuticals with a short position of SNDL. Check out your portfolio center. Please also check ongoing floating volatility patterns of AcelRx Pharmaceuticals and SNDL.
Diversification Opportunities for AcelRx Pharmaceuticals and SNDL
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between AcelRx and SNDL is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding AcelRx Pharmaceuticals and SNDL Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SNDL Inc and AcelRx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AcelRx Pharmaceuticals are associated (or correlated) with SNDL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SNDL Inc has no effect on the direction of AcelRx Pharmaceuticals i.e., AcelRx Pharmaceuticals and SNDL go up and down completely randomly.
Pair Corralation between AcelRx Pharmaceuticals and SNDL
If you would invest 101.00 in AcelRx Pharmaceuticals on September 14, 2024 and sell it today you would earn a total of 0.00 from holding AcelRx Pharmaceuticals or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 1.59% |
Values | Daily Returns |
AcelRx Pharmaceuticals vs. SNDL Inc
Performance |
Timeline |
AcelRx Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
SNDL Inc |
AcelRx Pharmaceuticals and SNDL Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AcelRx Pharmaceuticals and SNDL
The main advantage of trading using opposite AcelRx Pharmaceuticals and SNDL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AcelRx Pharmaceuticals position performs unexpectedly, SNDL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SNDL will offset losses from the drop in SNDL's long position.AcelRx Pharmaceuticals vs. Lifecore Biomedical | AcelRx Pharmaceuticals vs. Shuttle Pharmaceuticals | AcelRx Pharmaceuticals vs. Catalent | AcelRx Pharmaceuticals vs. Tilray Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |